Hydroxychloroquine for COVID-19 Post-exposure Prophylaxis (PEP)

NCT04328961 · clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
943
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University of Washington

Collaborators